Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

• Status: Recruiting
• Trial end date: 2023-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the effect of hypertonic saline 23.4% injection in fistulas or sinus tracts in adult patients with hidradenitis suppurativa.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beth Israel Deaconess Medical Center; Massachusetts General Hospital

Criteria

Inclusion Criteria:

• Male or female subjects are at least 18 years of age or older

• A confirmed diagnosis of HS disease

• Presence of inflammatory HS lesion(s) and one or more fistula(s) or sinus tracts

Exclusion Criteria:

• Receiving any other kind of treatment for fistulas including introduction of anti-inflammatory systemic therapy such as prednisone or adalimumab within the prior month.

• Are participating in another study using an investigational agent or procedure during participation in this study.

• Have any condition that, in the opinion of the investigator, would compromise the well-being of the subject or the study.